Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Insurance committee advances bill to require coverage of biomarker tests for treatment and management
Summary
The Tennessee House Insurance Committee voted 16-1 on March 19 to advance House Bill 484, which would require insurers to cover biomarker testing when ordered by a provider for diagnosis, treatment and management of a condition; members debated a distinction between screening and treatment.
The Tennessee House Insurance Committee on March 19 voted 16-1 to advance House Bill 484, as amended, which would require insurers to cover biomarker testing when ordered by a provider for diagnosis, treatment and management of a condition. Chairman Martin, sponsor of the bill, explained the proposal and its guardrails.
"The intent of this bill is to get patients across Tennessee the right treatment at the right time, timely diagnosis, and appropriate management for conditions," Chairman Martin told the committee, summarizing the amended language that excludes…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
